Dechant Robert Thomas sold 25,000 IBEX Ltd shares at $39.99 per share on Sept. 15, leaving him with 262,011 shares. The transaction represented about 8.7% of his prior holding, giving investors a specific measure of the stake reduction reported in the insider transaction.
Key Highlights
- The transaction was dated 15 September 2026.
- The sale carried SEC transaction code S, identifying it as an open-market sale.
- Thomas was identified as chief executive officer of IBEX Ltd.
Dechant Robert Thomas’s IBEX Ltd holding stood at 262,011 shares after he sold part of his position in a transaction representing about 8.7% of his prior holding. The sale involved 25,000 shares at $39.99 per share and was dated 15 September 2026.
IBEX Insider Sale Details
The reported sale covered 25,000 shares, with each share priced at $39.99. The SEC transaction code was S, which classifies the transaction as an open-market sale. The reported ownership figure following the transaction was 262,011 shares of IBEX Ltd. The transaction represented about 8.7% of Thomas’s prior shareholding. The reported figures identify the size, price and resulting ownership associated with the insider transaction.
FAQs
Q: How many IBEX Ltd shares did Dechant Robert Thomas sell?
A: Dechant Robert Thomas sold 25,000 IBEX Ltd shares. The transaction price was $39.99 per share, and it was dated 15 September 2026.
Q: How many IBEX shares did Thomas own after the transaction?
A: Thomas owned 262,011 IBEX Ltd shares following the transaction. He was identified as the company’s chief executive officer.
Q: What does transaction code S mean in the IBEX insider transaction?
A: SEC transaction code S identifies an open-market sale. The reported transaction involved Thomas selling 25,000 IBEX Ltd shares at $39.99 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.